Form 8-K - Current report:
SEC Accession No. 0001206774-21-001419
Filing Date
2021-05-10
Accepted
2021-05-10 16:20:33
Documents
14
Period of Report
2021-05-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT geron3907701-8k.htm   iXBRL 8-K 23635
2 PRESS RELEASE DATED MAY 10, 2021 geron3907701-ex991.htm EX-99.1 47879
3 GRAPHIC geron3907701-ex991x1x1.jpg GRAPHIC 4012
  Complete submission text file 0001206774-21-001419.txt   259841

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA gern-20210510.xsd EX-101.SCH 3014
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gern-20210510_pre.xml EX-101.PRE 22351
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE gern-20210510_lab.xml EX-101.LAB 34238
7 EXTRACTED XBRL INSTANCE DOCUMENT geron3907701-8k_htm.xml XML 3596
Mailing Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404
Business Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

EIN.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-20859 | Film No.: 21907518
SIC: 2834 Pharmaceutical Preparations